If you’re reading this, you’ve likely already made a critical decision: to embark on a weight loss journey. Perhaps this isn’t the first time. Maybe you’ve been on this road
GLP-1 agonists are transformative medications in aiding weight loss. However, these medications are most effective with strategic dietary choices. Eating protein first at every meal is super key.
GLP-1 Semaglutide can be a game-changer in managing weight. To succeed, we must change our habits and maximize its benefits. Here are the foundational rules I teach my Semaglutide patients
Believe it or not, your morning coffee can support your weight loss journey or derail your progress. Start your day off the right way with mindful eating and smart choices.
Navigating health challenges is never easy, especially when they involve an intimate and often misunderstood condition like lichen sclerosus. For anyone dealing with this, it’s important to know you’re not
Exercise is vital to any weight loss journey and body transformation. However, when taking GLP-1 medications like Semaglutide, it’s crucial to approach exercise differently. Many of us remember when we
As an ObGyn dedicated to helping patients achieve their weight loss goals, I often hear concerns about the side effects of GLP-1 medications, particularly nausea. If you’re experiencing this side
Take the first step in your weight loss journey.
The information provided in these COVID-19 blogs reflects guidelines, research, and recommendations available at the time of writing. As COVID-19 research and guidance continue to evolve, some details may no longer be current.
Low vaccination rates and a more contagious strain are a dangerous combination.
Only 4 vaccinated people were hospitalized with Covid-19.
Understanding the North Central Texas COVID- 19 Regional Infusion Center process.
Medical Director fired after promoting a back-to-school teen vaccine program.
BinaxNow rapid-response Covid-19 Test is a must-have item at home.
The Delta Variant is a whole new ballgame, and we need to pay attention.
